Source:http://linkedlifedata.com/resource/pubmed/id/12212616
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2002-9-4
|
pubmed:abstractText |
Urinary excretion of deoxypyridinoline (D-Pyr) has been shown to be a useful marker for bone resorption. In this study, we investigated whether D-Pyr could be used to monitor the changes in bone resorption of the hind limb induced by tail-suspension. Male Wistar rats 5-weeks old were tail-suspended in a metabolic cage to unload the hind limbs. The control rats were not suspended. YH529 (YH), an inhibitor of bone resorption, or a vehicle (phosphate buffered saline=PBS) was administered daily starting 3 days before the commencement of tail-suspension. In the non-suspended rats receiving PBS, urinary excretion of D-Pyr did not show any significant change during the one-week experimental period. In the non-suspended rats receiving YH, D-Pyr excretion significantly decreased on day 5 and 7 when compared with that observed on day 0, in accordance with the systemic inhibition of bone resorption by YH. In the tail-suspended rats receiving PBS, D-Pyr excretion showed a tendency to increase on day 1, which is in agreement with our previous report that tail-suspension causes an early (on day 1 of suspension) and transient increase in bone-resorption of the hind limbs. In the tail-suspended rats treated with YH, the increase in D-Pyr excretion on day 1 was not observed, and a significantly lower excretion was noted from day 3 to 7 during the tail-suspension. It was suggested that D-Pyr excretion might reflect the transient increase in hind limb bone resorption induced by tail-suspension. As observed in-YH treated rats, D-Pyr excretion could serve as a good marker for the inhibition of systemic bone resorption.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
S
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/YM 529,
http://linkedlifedata.com/resource/pubmed/chemical/deoxypyridinoline
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0287-0517
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NASA
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11-3
|
pubmed:dateRevised |
2011-2-21
|
pubmed:meshHeading |
pubmed-meshheading:12212616-Amino Acids,
pubmed-meshheading:12212616-Animals,
pubmed-meshheading:12212616-Biological Markers,
pubmed-meshheading:12212616-Bone Resorption,
pubmed-meshheading:12212616-Diphosphonates,
pubmed-meshheading:12212616-Hindlimb Suspension,
pubmed-meshheading:12212616-Imidazoles,
pubmed-meshheading:12212616-Male,
pubmed-meshheading:12212616-Rats,
pubmed-meshheading:12212616-Rats, Wistar,
pubmed-meshheading:12212616-Weightlessness Countermeasures,
pubmed-meshheading:12212616-Weightlessness Simulation
|
pubmed:year |
1998
|
pubmed:articleTitle |
Changes in urinary excretion of deoxypyridinoline in tail-suspended rats: effects of a bisphosphonate, YH529.
|
pubmed:affiliation |
Department of Endocrinology and Metabolism, Division of Molecular Adaptation, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.
|
pubmed:publicationType |
Journal Article
|